Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 96
Filter
1.
J Periodontal Res ; 53(3): 334-344, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29193068

ABSTRACT

BACKGROUND AND OBJECTIVES: Diabetes mellitus (DM) is a risk factor for periodontal diseases and may exacerbate the progression of the pathogenesis of periodontitis. Advanced glycation end-products (AGEs) cause DM complications relative to levels of glycemic control and larger amounts accumulate in the periodontal tissues of patients with periodontitis and DM. In the present study, we investigated the effects of AGEs on the expression of inflammation-related factors in human gingival fibroblasts (HGFs) to elucidate the impact of AGEs on DM-associated periodontitis. MATERIAL AND METHODS: HGFs were cultured with or without AGEs. Cell viability was examined, and RNA and protein fractions were isolated from AGE-treated cells. The expression of interleukin (IL)-6, intercellular adhesion molecule-1 (ICAM-1), and the receptor for AGE (RAGE) was investigated using reverse transcription-polymerase chain reaction, quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay, and reactive oxygen species activity was measured using a kit with 2',7'-dichlorofluorescin diacetate. Human monocytic cells (THP-1) labeled with a fluorescent reagent were co-cultured with HGFs treated with AGEs and IL-6 siRNA, and the adhesive activity of THP-1 cells to HGFs was assessed. The expression of IL-6 and ICAM-1 was examined when HGFs were pretreated with recombinant human IL-6, the siRNAs of RAGE and IL-6, and inhibitors of MAPK and NF-κB, and then cultured with and without AGEs. The phosphorylation of MAPK and NF-κB was assessed using western blotting. RESULTS: AGEs increased the mRNA and protein expressions of RAGE, IL-6, ICAM-1 and reactive oxygen species activity in HGFs, and promoted the adhesion of THP-1 cells to HGFs, but had no effect on cell viability until 72 hours. Recombinant human IL-6 increased ICAM-1 expression in HGFs, while the siRNAs of RAGE and IL-6 inhibited AGE-induced IL6 and ICAM1 mRNA expression, and IL-6 siRNA depressed AGE-induced THP-1 cell adhesion. AGEs increased the phosphorylation of p38 and ERK MAPKs, p65 NF-κB and IκBα, while inhibitors of p38, ERK MAPKs and NF-κB significantly decreased AGE-induced IL-6 and ICAM-1 expression. CONCLUSION: AGEs increase IL-6 and ICAM-1 expression via the RAGE, MAPK and NF-κB pathways in HGFs and may exacerbate the progression of the pathogenesis of periodontal diseases.


Subject(s)
Antigens, Neoplasm/metabolism , Fibroblasts/drug effects , Gingiva/drug effects , Glycation End Products, Advanced/pharmacology , Intercellular Adhesion Molecule-1/biosynthesis , Interleukin-6/biosynthesis , MAP Kinase Signaling System/drug effects , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , Diabetes Complications/metabolism , Fibroblasts/metabolism , Gingiva/cytology , Gingiva/metabolism , Humans , Intercellular Adhesion Molecule-1/metabolism , Interleukin-6/metabolism , Periodontitis/metabolism , Phosphorylation , Reactive Oxygen Species/metabolism , THP-1 Cells
2.
Eur J Surg Oncol ; 42(6): 829-35, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26968228

ABSTRACT

BACKGROUNDS: Perioperative introduction of developed chemotherapy into the treatment strategy for locally advanced rectal cancer (LARC) may be a promising option. However, the most prevalent treatment for high-risk LARC remains preoperative chemoradiotherapy (CRT) in Western countries. PATIENTS AND METHODS: A phase II trial was undertaken to evaluate safety and efficacy of perioperative XELOX without radiotherapy (RT) for patients with high-risk LARC. Patients received 4 cycles of XELOX before and after surgery, respectively. Primary endpoint was disease-free survival. RESULTS: We enrolled 41 patients between June 2012 and April 2014. The completion rate of the preoperative XELOX was 90.3%. Twenty-nine patients (70.7%) could start postoperative XELOX, 15 of these patients (51.7%) completed 4 cycles. Allergic reaction to oxaliplatin was experienced by 5 patients (17.2%) during postoperative XELOX. One patient received additional RT after preoperative XELOX. Consequently, the remaining 40 patients underwent primary resection. Major complications occurred in 6 of 40 patients (15.0%). Pathological complete response (pCR) rate was 12.2%, and good tumor regression was exhibited in 31.7%. N down-staging (cN+ to ypN0) and T down-staging were detected in 56.7% and 52.5%, respectively. Clinical T4 tumor was a predictor of poor pathological response (p < 0.001). CONCLUSIONS: We could show the favorable pCR rate after preoperative XELOX alone. However, the T and N down-staging rate was likely to be insufficient. When tumor regression is essential for curative resection, the use of preoperative CRT is likely to be recommended. For patients with massive LN metastasis, the additional Bev to NAC might be a promising option.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Neoadjuvant Therapy/methods , Rectal Neoplasms/drug therapy , Rectal Neoplasms/surgery , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Capecitabine/administration & dosage , Chemotherapy, Adjuvant , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Disease-Free Survival , Female , Fluorouracil/administration & dosage , Fluorouracil/analogs & derivatives , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Staging , Organoplatinum Compounds/administration & dosage , Oxaliplatin , Oxaloacetates , Rectal Neoplasms/mortality , Rectal Neoplasms/pathology , Risk , Treatment Outcome
3.
J Periodontal Res ; 51(3): 313-20, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26223811

ABSTRACT

BACKGROUND AND OBJECTIVES: Diabetes is a major risk factor for periodontitis and there is a close relationship between the degree of hyperglycemia and the severity of periodontitis. Advanced glycation end-products (AGEs) accumulate in various tissues under diabetic conditions. AGEs in the periodontal tissues probably play a role in upregulating periodontal inflammation; however, the association of AGEs with the severity of periodontitis has not been fully clarified. Lipopolysaccharide from Porphyromonas gingivalis (P-LPS) is a potent pathogenic factor in periodontitis. Although the independent effect of AGE or P-LPS on osteoblastic cells has been reported in vitro, the effect of adding both has not been clearly elucidated. In this study, to explore factors aggravating diabetic periodontitis, we investigated the effects of AGE and P-LPS on the expression of osteoblastic markers and the expression of inflammation-related markers in vitro. MATERIAL AND METHODS: Rat bone marrow cells were cultured, and alkaline phosphatase activity and bone nodule formation were evaluated as osteoblastic markers. Reverse transcription-polymerase chain reaction was performed to determine the mRNA expression of molecules associated with bone and inflammation. Protein levels of osteocalcin and interleukin-1ß (IL-1ß) were measured using enzyme-linked immunosorbent assay. RESULTS: AGEs and P-LPS independently reduced alkaline phosphatase activity and bone nodule formation. The addition of both AGE and P-LPS (AGE+P-LPS) further decreased these markers. Reverse transcription-polymerase chain reaction analysis revealed that AGE+P-LPS markedly decreased the mRNA expression of osteoblast-related molecules such as type 1 collagen, osteocalcin and Cbfa1, and markedly increased that of inflammation-related molecules such as IL1ß and S100A8. AGE and P-LPS decreased the protein level of osteocalcin and increased that of IL-1ß, and a further increase of IL-1ß was detected for AGE+P-LPS. CONCLUSION: AGEs and P-LPS inhibited the expression of osteoblastic markers and increased the levels of inflammatory markers in rat bone marrow cells, suggesting that both AGE and P-LPS may be important factors associated with the aggravation of diabetic periodontitis.


Subject(s)
Bone Marrow Cells/drug effects , Cells, Cultured/drug effects , Glycation End Products, Advanced/antagonists & inhibitors , Lipopolysaccharides/antagonists & inhibitors , Porphyromonas gingivalis/metabolism , Alkaline Phosphatase/analysis , Alkaline Phosphatase/drug effects , Animals , Cell Survival/drug effects , Diabetes Complications , Drug Combinations , Enzyme-Linked Immunosorbent Assay , Glycation End Products, Advanced/administration & dosage , Interleukin-1beta/metabolism , Lipopolysaccharides/administration & dosage , Male , Osteoblasts/drug effects , Osteoblasts/metabolism , Osteocalcin/metabolism , Osteogenesis/drug effects , Periodontitis/etiology , Periodontitis/metabolism , Polymerase Chain Reaction , RNA, Messenger/metabolism , Rats , Rats, Wistar , Time Factors
4.
J Oral Rehabil ; 41(11): 843-52, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25040436

ABSTRACT

Nonodontogenic toothache is a painful condition that occurs in the absence of a clinically evident cause in the teeth or periodontal tissues. The purpose of this review is to improve the accuracy of diagnosis and the quality of dental treatment regarding nonodontogenic toothache. Electronic databases were searched to gather scientific evidence regarding related primary disorders and the management of nonodontogenic toothache. We evaluated the level of available evidence in scientific literature. There are a number of possible causes of nonodontogenic toothache and they should be treated. Nonodontogenic toothache can be categorised into eight groups according to primary disorders as follows: 1) myofascial pain referred to tooth/teeth, 2) neuropathic toothache, 3) idiopathic toothache, 4) neurovascular toothache, 5) sinus pain referred to tooth/teeth, 6) cardiac pain referred to tooth/teeth, 7) psychogenic toothache or toothache of psychosocial origin and 8) toothache caused by various other disorders. We concluded that unnecessary dental treatment should be avoided.


Subject(s)
Toothache , Diagnosis, Differential , Facial Pain/complications , Humans , Myocardial Ischemia/complications , Myofascial Pain Syndromes/complications , Neuralgia/complications , Sinusitis/complications , Toothache/classification , Toothache/diagnosis , Toothache/etiology , Toothache/therapy
5.
Hernia ; 18(2): 213-9, 2014 Apr.
Article in English | MEDLINE | ID: mdl-23657862

ABSTRACT

BACKGROUND: The aim of this study was to assess whether the application of a lightweight mesh for mesh plug repair (MPR) for primary inguinal hernia could reduce chronic pain or other symptoms associated with the insertion of the prosthesis. METHODS: Patients over 20 years of age with a unilateral primary inguinal hernia were eligible to participate in the study. The patients were randomly assigned to a lightweight mesh (LWM) or a heavyweight mesh (HWM) group. All the operations were performed under local anesthesia. The operative details, including the hernia type and the nerves that were identified, and the postoperative complications were recorded. All follow-up and outcome measures were obtained based on a physical examination and a questionnaire regarding pain and other symptoms at 1 week, 1, 3, 6, and 12 months after the surgery in a double-blinded manner. RESULTS: The use of LWM significantly reduced foreign body sensation after 12 months to one-third of the incidence reported for the use of HWM (5.8 vs. 17.9%; P = 0.013), while no significant differences were found in pain parameters, including the use of pain relief medications, between the groups throughout the study period. CONCLUSION: This study indicated that the use of LWM in the MPR decreases the incidence of foreign body sensation at 1 year after surgery for primary inguinal hernia. LWM may be preferable to MPR, similar to results described previously for Lichtenstein repair.


Subject(s)
Hernia, Inguinal/surgery , Herniorrhaphy/methods , Surgical Mesh , Aged , Anesthesia, Local , Double-Blind Method , Female , Humans , Incidence , Length of Stay/statistics & numerical data , Male , Operative Time , Pain Measurement , Pain, Postoperative/prevention & control , Postoperative Complications/epidemiology , Prosthesis Design , Surveys and Questionnaires , Treatment Outcome
6.
Oncogene ; 33(23): 2978-86, 2014 Jun 05.
Article in English | MEDLINE | ID: mdl-23893245

ABSTRACT

Sgf29, a component of the SPT-ADA-GCN5 acetyltransferase (SAGA) complex, binds H3K4me2/3 marks and leads to histone H3 acetylation. Previously, we found that downregulation of Sgf29 suppresses c-Myc-mediated malignant transformation. Nonetheless, the upstream regulator of the Sgf29 gene is not yet known. Here, we report that Sry (sex-determining region Y), an HMG (high-mobility group) domain containing transcription factor, directly upregulates Sgf29 gene expression. Sry expression was deregulated in two out of the four tested male rodent hepatocellular carcinoma (rHCC) cell lines. Luciferase reporter and chromatin immunoprecipitation assays indicated that Sry could bind HMG-boxes in the proximal promoter region of the Sgf29 gene. Knockdown of Sry robustly lowered anchorage-independent growth, invasiveness and tumorigenicity of rHCC cells, whereas ectopic expression of Sry conferred more malignant properties. Thus, these data show that Sry is involved in male-specific malignant conversion of rHCCs via Sgf29 upregulation.


Subject(s)
Acetyltransferases/metabolism , Carcinogenesis , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/metabolism , Sex-Determining Region Y Protein/metabolism , Acetyltransferases/genetics , Animals , Cell Line , Cell Line, Tumor , Gene Expression Regulation, Neoplastic , Gene Knockdown Techniques , HMG-Box Domains , Histone Acetyltransferases/genetics , Histone Acetyltransferases/metabolism , Male , Mice , Mice, SCID , Neoplasm Invasiveness , Promoter Regions, Genetic , Protein Structure, Tertiary , Rats , Sex-Determining Region Y Protein/genetics
7.
Rev Port Pneumol ; 20(2): 69-77, 2014.
Article in English | MEDLINE | ID: mdl-24290563

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the effectiveness of implementing a physical therapy guideline for patients undergoing upper abdominal surgery (UAS) in reducing the incidence of atelectasis and length of hospital stay in the postoperative period. MATERIALS AND METHODS: A "before and after" study design with historical control was used. The "before" period included consecutive patients who underwent UAS before guideline implementation (intervention). The "after" period included consecutive patients after guideline implementation. Patients in the pre-intervention period were submitted to a program of physical therapy in which the treatment planning was based on the individual experience of each professional. On the other hand, patients who were included in the post-intervention period underwent a standardized program of physical therapy with a focus on the use of additional strategies (EPAP, incentive spirometry and early mobilization). RESULTS: There was a significant increase in the use of incentive spirometry and positive expiratory airway pressure after guideline implementation. Moreover, it was observed that early ambulation occurred in all patients in the post-intervention period. No patient who adhered totally to the guideline in the post-intervention period developed atelectasis. Individuals in the post-intervention period presented a shorter length of hospital stay (9.2±4.1 days) compared to patients in the pre-intervention period (12.1±8.3 days) (p<0.05). CONCLUSION: The implementation of a physical therapy guideline for patients undergoing UAS resulted in reduced incidence of atelectasis and reduction in length of hospital stay in the postoperative period.


Subject(s)
Abdomen/surgery , Length of Stay/statistics & numerical data , Physical Therapy Modalities , Postoperative Care , Pulmonary Atelectasis/epidemiology , Pulmonary Atelectasis/prevention & control , Clinical Protocols , Female , Humans , Incidence , Male , Middle Aged , Practice Guidelines as Topic , Retrospective Studies , Treatment Outcome
8.
Am J Physiol Endocrinol Metab ; 305(8): E987-98, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-23964070

ABSTRACT

The prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is increasing with the growing epidemics of obesity and diabetes. NAFLD encompasses a clinicopathologic spectrum of disease ranging from isolated hepatic steatosis to NASH, which is a more aggressive form of fatty liver disease, to cirrhosis and, finally, hepatocellular carcinoma (HCC). The exact mechanism behind the development of HCC in NASH remains unclear; however, it has been established that hepatic steatosis is the important risk factor in the development of HCC. Metformin has recently drawn attention because of its potential antitumor effect. Here, we investigated the effects of metformin on high-fat diet (HFD)-induced liver tumorigenesis, using a mouse model of NASH and liver tumor. Metformin prevented long-term HFD-induced liver tumorigenesis in C57Bl/6 mice. Of note, metformin failed to protect against liver tumorigenesis in mice that had already begun to develop NAFLD. Metformin improved short-term HFD-induced fat accumulation in the liver, associated with the suppression of adipose tissue inflammation. Collectively, these results suggest that metformin may prevent liver tumorigenesis via suppression of liver fat accumulation in the early stage, before the onset of NAFLD, which seems to be associated with a delay in the development of inflammation of the adipose tissue.


Subject(s)
Anticarcinogenic Agents/therapeutic use , Carcinogenesis/drug effects , Fatty Liver/prevention & control , Hypoglycemic Agents/therapeutic use , Liver Neoplasms/prevention & control , Liver/drug effects , Metformin/therapeutic use , Adipose Tissue, White/drug effects , Adipose Tissue, White/immunology , Adipose Tissue, White/pathology , Animals , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/prevention & control , Diet, High-Fat/adverse effects , Disease Progression , Fatty Liver/etiology , Fatty Liver/pathology , Fatty Liver/physiopathology , Lipid Metabolism/drug effects , Liver/immunology , Liver/metabolism , Liver/pathology , Liver Neoplasms/etiology , Male , Mice , Mice, Inbred C57BL , Non-alcoholic Fatty Liver Disease , Obesity/complications , Random Allocation
9.
J Neuroendocrinol ; 25(9): 811-25, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23841557

ABSTRACT

Vasotocin-producing parvocellular neurones in the medial part of the bed nucleus of the stria terminalis (BSTM) of many species of birds and mammals show sexual dimorphism and great plasticity in response to hormonal and environmental stimuli. In the BSTM of Japanese quail, vasotocin-immunoreactive neurones are visible and sensitive to testosterone exclusively in males. In males, gonadectomy decreases and testosterone restores vasotocin-immunoreactive cells and fibres by acting on vasotocin mRNA transcription. The insensitivity of female vasotocin-immunoreactive neurones to the activating effects of testosterone is the result of organisational effects of early exposure to oestradiol. Female quail also show vasotocin mRNA-expressing neurones in the BSTM, although it is not known whether the insensitivity of the vasotocinergic neurones to testosterone originates at the level of vasotocin gene transcription in this sex. Therefore, initially, the present study analysed the effects of acute treatment with testosterone on vasotocin mRNA expression in the BSTM of gonadectomised male and female quail using in situ hybridisation. Gonadectomy decreased (and a single injection of testosterone increased) the number of vasotocin mRNA-expressing neurones and intensity of the vasotocin mRNA hybridisation signal similarly in both sexes. Notably, testosterone increased vasotocin mRNA expression in ovariectomised females over that shown by intact quail. However, this treatment had no effect on vasotocin immunoreactivity. A second experiment analysed the effects of testosterone metabolites, oestradiol and 5α-dihydrotestosterone, on vasotocin mRNA expression in female quail. Oestradiol (but not 5α-dihydrotestosterone) fully mimicked the effects of testosterone on the number of vasotocin mRNA-expressing neurones and the intensity of the vasotocin mRNA hybridisation signal. Taken together, these results show, for the first time, that gonadal steroids strongly activate vasotocin mRNA expression in the BSTM of female quail.


Subject(s)
Coturnix , Septal Nuclei/drug effects , Septal Nuclei/metabolism , Testosterone/pharmacology , Vasotocin/biosynthesis , Animals , Coturnix/genetics , Coturnix/metabolism , Dihydrotestosterone/pharmacology , Estradiol/pharmacology , Female , Gene Expression Regulation/drug effects , Male , Neurons/drug effects , Neurons/metabolism , RNA, Messenger/metabolism
10.
J Comp Pathol ; 149(2-3): 291-7, 2013.
Article in English | MEDLINE | ID: mdl-23570943

ABSTRACT

Systemic amyloid-A (AA) amyloidosis in birds occurs most frequently in waterfowl such as Pekin ducks. In chickens, AA amyloidosis is observed as amyloid arthropathy. Outbreaks of systemic amyloidosis in flocks of layers are known to be induced by repeated inflammatory stimulation, such as those resulting from multiple vaccinations with oil-emulsified bacterins. Outbreaks of fatal AA amyloidosis were observed in growing chickens in a large scale poultry farm within 3 weeks of vaccination with multiple co-administered vaccines. This study documents the histopathological changes in tissues from these birds. Amyloid deposits were also observed at a high rate in the tissues of apparently healthy chickens. Vaccination should therefore be considered as a potential risk factor for the development of AA amyloidosis in poultry.


Subject(s)
Amyloidosis/veterinary , Poultry Diseases/epidemiology , Vaccination/adverse effects , Adenoviridae Infections/prevention & control , Amyloidosis/epidemiology , Amyloidosis/etiology , Amyloidosis/pathology , Animals , Atadenovirus , Bacterial Vaccines/adverse effects , Chickens , Common Cold/prevention & control , Immunohistochemistry , Incidence , Mycoplasma Infections/prevention & control , Mycoplasma gallisepticum , Newcastle Disease/prevention & control , Poultry Diseases/etiology , Poultry Diseases/pathology , Salmonella Infections/prevention & control , Viral Vaccines/adverse effects
11.
Endoscopy ; 45(4): 265-71, 2013.
Article in English | MEDLINE | ID: mdl-23322477

ABSTRACT

BACKGROUND AND STUDY AIMS: Acute colorectal obstruction (ACO) often accompanies colorectal cancer (CRC) and requires urgent treatment, but achieving elective laparoscopy-assisted colectomy (LAC) is difficult in this setting. The aim of the current study was to assess the clinical outcomes of a transanal tube (Dennis colorectal tube [DCT]) for CRC with ACO, focusing in particular on the impact of the DCT on subsequent elective LAC. PATIENTS AND METHODS: Among 1142 patients who underwent surgery for CRC between January 2007 and December 2011, 92 patients with ACO were identified retrospectively. Of these 92 patients, the DCT procedure was performed in 66 patients who fulfilled the indications for DCT, and these patients were included in the study. RESULTS: All 66 patients presented with complete obstruction. Technical and clinical success rates for DCT were 93.9 % and 86.4 %, respectively. Perforation after DCT occurred in 4.5 % and the mortality rate was 1.5 %. The rate of LAC was 48.5 %, and the rate of primary stoma was 13.6 %. For curative stage II/III CRC with ACO, DCT resulted in a primary stoma rate of 13.6 %, a one-stage surgery rate of 90.9 %, a LAC rate of 50.0 %, and a 3-year survival rate of 73.1 %. For stage II/III CRC cases with clinical success by DCT, the one-stage surgery rate was 97.4 % and the LAC rate was 56.4 %. CONCLUSIONS: DCT achieved a high rate of clinical success and enabled safe one-stage surgery and LAC for CRC with ACO. DCT followed by LAC is proposed as a promising non-invasive strategy for CRC with ACO.


Subject(s)
Colorectal Neoplasms/surgery , Drainage/methods , Intestinal Obstruction/surgery , Intestinal Perforation/etiology , Intubation, Gastrointestinal/methods , Adult , Aged , Aged, 80 and over , Anal Canal , Colectomy , Colorectal Neoplasms/complications , Colorectal Neoplasms/pathology , Colostomy , Drainage/instrumentation , Female , Humans , Intestinal Obstruction/etiology , Intestinal Obstruction/pathology , Intubation, Gastrointestinal/adverse effects , Kaplan-Meier Estimate , Laparoscopy , Male , Middle Aged , Preoperative Care , Retrospective Studies , Statistics, Nonparametric , Young Adult
12.
Exp Clin Endocrinol Diabetes ; 120(3): 139-44, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22068616

ABSTRACT

BACKGROUND: Angiopoietin-like protein 4 (Angptl4) is thought to cause an increase in serum triglyceride levels. In the present study, we elucidated Angptl4 expression in the mouse models of type 1 and type 2 diabetes mellitus, and investigated the possible mechanisms involved. METHODS: Type 1 diabetes was induced in C57BL/6 J mice by treating them with streptozotocin (STZ). Type 2 diabetes was induced by feeding the mice a high-fat diet (HFD) for 18 weeks. RESULTS: The levels of Angptl4 mRNA expression in liver, white adipose tissue (WAT), and brown adipose tissue (BAT) were found to increase in the STZ diabetic mice relative to control mice. This effect was attenuated by insulin administration. In the HFD diabetic mice, the Angptl4 mRNA expression levels were increased in liver, WAT, and BAT. Treatment with metformin for 4 weeks attenuated the increased levels of Angptl4 mRNA. Fatty acids (FAs) such as palmitate and linoleate induced Angptl4 mRNA expression in H4IIE hepatoma cells and 3T3-L1 adipocytes. Treatment with insulin but not metformin attenuated FA-induced Angptl4 mRNA expression in H4IIE. Both insulin and metformin did not influence the effect of FAs in 3T3-L1 cells. CONCLUSION: These observations demonstrated that Angptl4 mRNA expression was increased through the elevated free FAs in diabetic mice.


Subject(s)
Angiopoietins/genetics , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/metabolism , Fatty Acids, Nonesterified/metabolism , Insulin/metabolism , 3T3-L1 Cells , Angiopoietin-Like Protein 4 , Angiopoietins/metabolism , Animals , Cell Line, Tumor , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/etiology , Diet, High-Fat , Down-Regulation/drug effects , Fatty Acids, Nonesterified/blood , Fatty Acids, Nonesterified/pharmacology , Gene Expression Regulation/drug effects , Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Male , Metformin/pharmacology , Mice , Mice, Inbred C57BL , Rats , Signal Transduction/drug effects , Signal Transduction/genetics , Streptozocin , Up-Regulation/drug effects , Up-Regulation/genetics
13.
Bone Marrow Transplant ; 42(1): 43-9, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18347569

ABSTRACT

Bronchiolitis obliterans syndrome (BOS) and idiopathic pneumonia syndrome (IPS) cause high mortality and impaired survival after allogeneic hematopoietic stem-cell transplantation (allo-HSCT). Early recognition of patients at high risk of developing BOS/IPS may lead to improving the outcome of allo-HSCT. We retrospectively analyzed serum surfactant protein A, D (SP-A, -D) and Kerbs von Lungren 6 Ag (KL-6) levels before allo-HSCT in 56 patients who survived more than 90 days after allo-HSCT and compared values of these serum markers and other transplant factors in BOS/IPS patients with those in non-BOS/IPS patients. Five patients developed BOS and two developed IPS at a median interval of 303 and 117 days (range, 100-452 and 95-153) from transplantation. As a result of univariate analysis, pretransplant serum SP-D levels but not SP-A, KL-6 in BOS/IPS patients were significantly lower than those in non-BOS/IPS patients (P=0.03). In multivariate analysis, the patients with lower pretransplant serum SP-D level had a trend toward frequent development of BOS/IPS (P=0.08). Constitutive serum SP-D level before allo-HSCT may be a useful, noninvasive predictor for the development of BOS/IPS.


Subject(s)
Bronchiolitis Obliterans/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Pneumonia/etiology , Pulmonary Surfactant-Associated Protein D/blood , Adolescent , Adult , Aged , Biomarkers/blood , Cohort Studies , Female , Humans , Male , Middle Aged , Mucin-1/blood , Prognosis , Pulmonary Surfactant-Associated Protein A/blood , Retrospective Studies , Syndrome , Transplantation, Homologous
14.
J Oral Rehabil ; 33(6): 402-8, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16671985

ABSTRACT

Chin-tuck position and reclining posture have been used in dysphagia patients to prevent aspiration during swallowing. However, both behavioural treatments may affect respiratory function. This study was carried out to test the hypothesis that if chin-tuck posture and body reclining affected respiratory function, this would be associated with altered coordination between respiration and swallowing. To investigate this hypothesis, respiratory parameters and manometry were used in each of four combinations of reclining posture and chin-tuck position. In the 60 degrees reclining with 60 degrees chin-tuck position, duration of swallowing apnea (0.89 s.d. 0.17 s) and submental electromyography burst (2.34 s.d. 0.84 s) were significantly longer when compared to both upright sitting and 30 degrees reclining positions. We conclude that 60 degrees reclining from vertical with 60 degrees chin-tuck may affect oral processing stages which delay and reduce a variety of oropharyngeal movements. These in turn significantly influence the coordination between respiration and swallowing.


Subject(s)
Deglutition/physiology , Posture/physiology , Reflex , Respiration , Adult , Analysis of Variance , Electromyography , Humans , Male , Manometry , Statistics, Nonparametric
15.
J Dent Res ; 84(6): 554-8, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15914594

ABSTRACT

It has been proposed that advancement of the mandible is a useful method for decreasing upper airway collapsibility. We carried out this study to test the hypothesis that mandibular advancement induces changes in upper airway patency during midazolam sedation. To explore its effect, we examined upper airway pressure-flow relationships in each of 4 conditions of mouth position in normal, healthy subjects (n = 9). In the neutral position, Pcrit (i.e., critical closing pressure, an index of upper airway collapsibility) was -4.2 cm H(2)O, and upstream resistance (Rua) was 21.2 cm H(2)O/L/sec. In the centric occlusal position, Pcrit was -7.1 cm H(2)O, and Rua was 16.6 cm H(2)O/L/sec. In the incisor position, Pcrit was significantly reduced to -10.7 cm H(2)O, and Rua was significantly reduced to 14.0 cm H(2)O/L/sec. Mandibular advancement significantly decreased Pcrit to -13.3 cm H(2)O, but did not significantly influence Rua (22.1 cm H(2)O/L/sec). We conclude that the mandibular incisors' position improved airway patency and decreased resistance during midazolam sedation.


Subject(s)
Airway Obstruction/physiopathology , Airway Resistance/physiology , Mandible/anatomy & histology , Adult , Airway Resistance/drug effects , Dental Occlusion, Centric , Humans , Hypnotics and Sedatives/administration & dosage , Hypnotics and Sedatives/pharmacology , Incisor/anatomy & histology , Inhalation/drug effects , Inhalation/physiology , Inspiratory Capacity/drug effects , Inspiratory Capacity/physiology , Male , Mandibular Advancement/instrumentation , Midazolam/administration & dosage , Midazolam/pharmacology , Polysomnography , Pressure , Pulmonary Ventilation/drug effects , Pulmonary Ventilation/physiology
16.
J Dent Res ; 83(9): 718-22, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15329379

ABSTRACT

Sedative doses of anesthetic agents affect upper-airway function. Oral-maxillofacial surgery is frequently performed on sedated patients whose mouths must be as open as possible if the procedures are to be accomplished successfully. We examined upper-airway pressure-flow relationships in closed mouths, mouths opened moderately, and mouths opened maximally to test the hypothesis that mouth-opening compromises upper-airway patency during midazolam sedation. From these relationships, upper-airway critical pressure (Pcrit) and upstream resistance (Rua) were derived. Maximal mouth-opening increased Pcrit to -3.6 +/- 2.9 cm H2O compared with -8.7 +/- 2.8 (p = 0.002) for closed mouths and -7.2 +/- 4.1 (p = 0.038) for mouths opened moderately. In contrast, Rua was similar in all three conditions (18.4 +/- 6.6 vs. 17.7 +/- 7.6 vs. 21.5 +/- 11.6 cm H2O/L/sec). Moreover, maximum mouth-opening produced an inspiratory airflow limitation at atmosphere that was eliminated when nasal pressure was adjusted to 4.3 +/- 2.7 cm H2O. We conclude that maximal mouth-opening increases upper-airway collapsibility, which contributes to upper-airway obstruction at atmosphere during midazolam sedation.


Subject(s)
Airway Resistance/physiology , Conscious Sedation , Hypnotics and Sedatives/administration & dosage , Midazolam/administration & dosage , Mouth/physiology , Pharynx/physiology , Adult , Airway Obstruction/etiology , Humans , Inhalation/physiology , Male , Nose/physiology , Polysomnography , Pressure , Pulmonary Ventilation/physiology
17.
Jpn J Antibiot ; 54(3): 103-11, 2001 Mar.
Article in Japanese | MEDLINE | ID: mdl-11392680

ABSTRACT

Diagnosis of fungal infections in compromised hosts has been difficult because of insufficient sensitivity and specificity of conventional methods such as culturing and serum testing. Therefore, antifungal agents are usually started in febrile patients who are resistant to antibiotics even if these monitoring tests were negative. In this study, therefore, in order to increase the reliability of these monitoring, polymerase chain reaction (PCR) methods for detection of blood fungus were also performed in compromised hosts including 14 patients with hematological malignancies and one with solid tumor who were undergoing chemotherapies. From these patients, total of 56 peripheral blood samples was collected periodically, irrespective of the presence of infectious signs. At each time point of venopuncture, status of the patient was allocated to one of the followings: A, receiving an intravenous antifungal therapy because of sustaining fever which had not responded to prior antibiotic therapies and also positive for culturing and/or serum beta-D-glucan tests; B, receiving an additional intravenous antifungal therapy but negative for culturing and serum-tests; C, febrile but not yet receiving any intravenous fungal therapy; D, afebrile status. During the study, 10 blood samples from 3 patients were allocated in group A, and one sample of them was positive while remaining 9 were all negative for PCR. Six samples from 4 patients were in group B, and one was PCR positive while remaining 5 were negative. Fifteen samples from 7 patients were in group C, and 3 were positive and 12 were negative for PCR. Twenty-five samples were in group D, and 5 were positive and 20 were negative for PCR. Thus, the results from fungal PCR in these patients were in some case showed discrepancies from those expected from the clinical course and/or conventional monitoring tests. Further evaluation of fungal PCR may gain insight into the more precise diagnosis of fungal infection in these patients.


Subject(s)
Immunocompromised Host , Mycoses/diagnosis , Opportunistic Infections/diagnosis , Polymerase Chain Reaction/methods , Adult , Female , Fungi/isolation & purification , Hematologic Neoplasms/complications , Humans , Male , Middle Aged , Mycoses/complications , Mycoses/microbiology , Opportunistic Infections/complications , Opportunistic Infections/microbiology
18.
Chem Pharm Bull (Tokyo) ; 48(11): 1822-5, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11086927

ABSTRACT

Rh-Catalyzed cyclization was applied to the formation of a chiral quaternary carbon. It has become clear that the Rh-complex can discriminate between isopropenyl and 2-isopentenyl (or isopentyl) substituents, and the cyclization afforded 3,3,4-trisubstituted cyclopentanones with a chiral quaternary carbon in a stereoselective manner. The cyclization of 4-pentenals 6a, b by an achiral neutral Rh(PPh3)3Cl afforded 3,3,4-cis-trisubstituted cyclopentanones (+/-)-7a,b in 86-96%, and the cyclization by a cationic Rh[(R)-BINAP]CIO4 afforded 3,3,4-trans-trisubstituted cyclopentanones (-)-8a, b of 82-86% ee in 88-98% yields. The mechanism of stereoselection by Rh-complexes is also discussed.


Subject(s)
Cyclopentanes/chemical synthesis , Rhodium/chemistry , Catalysis , Cyclization , Cyclopentanes/chemistry , Stereoisomerism
19.
J Org Chem ; 65(18): 5806-16, 2000 Sep 08.
Article in English | MEDLINE | ID: mdl-10970327

ABSTRACT

Asymmetric cyclization of symmetrical 3,4-disubstituted and 3,3, 4-trisubstituted 4-pentenals was studied using Rh-complexes with chiral ligands. The cyclization of symmetrical 4-pentenals 4a,b by a neutral Rh[(R)-BINAP]Cl afforded cis-3,4-disubstituted (4R)-cyclopentanones 9a,b of >95% ee in 25-31% yields; on the other hand, the cyclization of 4a-c by a cationic Rh[(R)-BINAP]ClO(4) afforded trans-3,4-disubstituted (4S)-cyclopentanones 10a-c of >95% ee in 70-81% yields. All stereoisomers could be stereoselectively made by the selection of a neutral or cationic Rh-complex, and (R)- or (S)-BINAP ligand. The Rh-catalyzed cyclization could be applied to the construction of cyclopentanones 17 and 18 bearing a chiral quaternary carbon. The cyclization by the cationic Rh[(R)-BINAP]ClO(4) afforded the optically active trans-3,3, 4-trisubstituted cyclopentanones 18a-c of 92-95% ee in 75-83% yields. The catalytic cycle was also studied by using deuterium aldehyde, and the tentative mechanisms of the enantio- and diastereoselection were proposed.

SELECTION OF CITATIONS
SEARCH DETAIL